Is RSLBF or DIVO a better dividend investment in 2026?

RSLBF currently yields 1.37% with a 5% 5-year dividend growth rate. DIVO yields 6.49% with 5% growth. The better choice depends on your goal: DIVO offers higher current income.

What is the dividend yield difference between RSLBF and DIVO?

RSLBF has a forward dividend yield of 1.37% ($0.31/share annually). DIVO yields 6.49% ($2.91/share annually). The yield gap is 5.12 percentage points.

Home › Compare › RSLBF vs DIVO

RSLBF vs DIVO: Dividend Comparison 2026

RSLBF yields 1.37% · DIVO yields 6.49%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 DIVO wins by $9.1K in total portfolio value

INVESTMENT

TIME HORIZON10 years

RSLBF

● Live price

1.37%

Share price

$23.00

Annual div

$0.31

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.6K

Annual income

$149.57

Full RSLBF calculator →

DIVO

● Live price

6.49%

Share price

$44.85

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$981.68

Full DIVO calculator →

Portfolio growth — RSLBF vs DIVO

📍 DIVO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	RSLBF	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, RSLBF + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

RSLBF pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RSLBF

Annual income on $10K today (after 15% tax)

$116.34/yr

After 10yr DRIP, annual income (after tax)

$127.13/yr

DIVO

Annual income on $10K today (after 15% tax)

$552.00/yr

After 10yr DRIP, annual income (after tax)

$834.43/yr

At 15% tax rate, DIVO beats the other by $707.29/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RSLBF + DIVO for your $10,000?

RSLBF: 50%DIVO: 50%

100% DIVO50/50100% RSLBF

Portfolio after 10yr

$26.2K

Annual income

$565.62/yr

Blended yield

2.16%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RSLBF buys

DIVO buys

No recent congressional trades found for RSLBF or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricRSLBFDIVO

Forward yield	1.37%	6.49% ✓
Annual dividend / share	$0.31	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$21.6K	$30.7K ✓
Annual income after 10y	$149.57	$981.68 ✓
Total dividends collected	$1.4K	$8.2K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: RSLBF vs DIVO ($10,000, DRIP)

Year	RSLBF Portfolio	RSLBF Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$10,837	$136.87	$11,349	$649.42	$512.00 → DIVO
2	$11,734	$138.62	$12,833	$688.83	$1.1K → DIVO
3	$12,696	$140.28	$14,459	$727.90	$1.8K → DIVO
4	$13,726	$141.84	$16,238	$766.49	$2.5K → DIVO
5	$14,830	$143.33	$18,179	$804.47	$3.3K → DIVO
6	$16,013	$144.72	$20,293	$841.71	$4.3K → DIVO
7	$17,280	$146.04	$22,591	$878.14	$5.3K → DIVO
8	$18,637	$147.29	$25,087	$913.65	$6.5K → DIVO
9	$20,090	$148.46	$27,791	$948.18	$7.7K → DIVO
10	$21,646	$149.57	$30,718	$981.68	$9.1K → DIVO

RSLBF vs DIVO: Complete Analysis 2026

RSLBF — Stock

RaySearch Laboratories AB (publ), a medical technology company, develops software solutions for cancer treatment worldwide. It develops and markets RayStation, a treatment planning system for treatment activities, such as automated planning, adaptive therapy, multi-criteria optimization, fast and accurate dose computations, OAR dose reduction, robustness, machine learning, VMAT, IMRT, 3D-CRT, virtual simulation, electron beam therapy, tomotherapy, stereotactic, proton therapy, carbon ion therapy, and boron neutron capture therapy. The company also develops RayPlan, a treatment planning system for supporting a range of treatment planning activities for 3D-CRT, IMRT, VMAT, tomotherapy, and electron beam radiation therapy; and RayCare, an oncology information system to support cancer treatment activities. In addition, it offers RayCommand, a treatment control system that is compatible with various hardware models and supports advanced functionalities of treatment machines and software systems; and RayIntelligence, a cloud-based oncology analytics system that turns patient data into insights. Further, the company provides training courses related to its products. RaySearch Laboratories AB (publ) is headquartered in Stockholm, Sweden.

Full RSLBF Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this RSLBF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RSLBF vs SCHD RSLBF vs JEPI RSLBF vs O RSLBF vs KO RSLBF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.